Literature DB >> 4372400

Hemagglutination-inhibition: rapid assay for neuraminic acid-containing viruses.

R W Compans.   

Abstract

Influenza virus particles bind rapidly to vesicular stomatitis, Sindbis, or Rauscher murine leukemia virus particles, forming mixed aggregates demonstrable by electron microscopy. The normal hemagglutinating property of influenza virus is inhibited by these viruses, providing a rapid quantitative assay. Prior treatment with neuraminidase blocks the ability of other viruses to inhibit influenza virus hemagglutination.

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4372400      PMCID： PMC355650     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  16 in total

1.  [The nature of cell receptors for the influenza virus].

Authors:  E KLENK; H LEMPFRID
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1957

2.  THE AGGLUTINATION OF RED CELLS BY ALLANTOIC FLUID OF CHICK EMBRYOS INFECTED WITH INFLUENZA VIRUS.

Authors:  G K Hirst
Journal:  Science       Date:  1941-07-04       Impact factor: 47.728

3.  Properties of mouse leukemia viruses. IV. Hemagglutination assay and characterization of hemagglutinating surface components.

Authors:  R Witter; H Frank; V Moennig; G Hunsmann; J Lange; W Schäfer
Journal:  Virology       Date:  1973-08       Impact factor: 3.616

4.  Differences between the envelope glycoproteins and glycopeptides of avian tumor viruses released from transformed and from nontransformed cells.

Authors:  M M Lai; P H Duesberg
Journal:  Virology       Date:  1972-11       Impact factor: 3.616

5.  Spin-labeled electron spin resonance study of the lipid-containing membrane of influenza virus.

Authors:  F R Landsberger; J Lenard; J Paxton; R W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205

6.  The proteins of the parainfluenza virus SV5. II. The carbohydrate content and glycoproteins of the virion.

Authors:  H D Klenk; L A Caliguiri; P W Choppin
Journal:  Virology       Date:  1970-10       Impact factor: 3.616

7.  Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity.

Authors:  P W Choppin
Journal:  Virology       Date:  1969-09       Impact factor: 3.616

8.  Carbohydrate composition of vesicular stomatitis virus.

Authors:  J J McSharry; R R Wagner
Journal:  J Virol       Date:  1971-03       Impact factor: 5.103

9.  Glycolipid content of vesicular stomatitis virus grown in baby hamster kidney cells.

Authors:  H D Klenk; P W Choppin
Journal:  J Virol       Date:  1971-03       Impact factor: 5.103

10.  Glycosphingolipids of plasma membranes of cultured cells and an enveloped virus (SV5) grown in these cells.

Authors:  H D Klenk; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1970-05       Impact factor: 11.205
View more
  26 in total

1.  Sialylatin of glycoproteins of murine mammary tumor virus, murine leukemia virus, and Mason-Pfizer monkey virus.

Authors:  R H Schloemer; J Schlom; G Schochetman; P Kimball; R R Wagner
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

2.  Structural components of mouse mammary tumor virus. II. Isolation and purification of virion polypeptides.

Authors:  M J Yagi; R E Stutzman; B H Robertson; R W Compans
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

3.  Structure of the membrane protein of influenza virus. I. Isolation and characterization of cyanogen bromide cleavage products.

Authors:  B H Robertson; A S Bhown; R W Compans; J C Bennett
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

4.  Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens.

Authors:  Sang-Moo Kang; Lizheng Guo; Qizhi Yao; Ioanna Skountzou; Richard W Compans
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

5.  Absence of neuraminidase from influenza C virus.

Authors:  K Nerome; M Ishida; M Nakayama
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

6.  Adjuvanted influenza vaccine administered intradermally elicits robust long-term immune responses that confer protection from lethal challenge.

Authors:  Maria del P Martin; Shaguna Seth; Dimitrios G Koutsonanos; Joshy Jacob; Richard W Compans; Ioanna Skountzou
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

7.  Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection.

Authors:  Bao-Zhong Wang; Rui Xu; Fu-Shi Quan; Sang-Moo Kang; Li Wang; Richard W Compans
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

8.  Dissolving polymer microneedle patches for influenza vaccination.

Authors:  Sean P Sullivan; Dimitrios G Koutsonanos; Maria Del Pilar Martin; Jeong Woo Lee; Vladimir Zarnitsyn; Seong-O Choi; Niren Murthy; Richard W Compans; Ioanna Skountzou; Mark R Prausnitz
Journal:  Nat Med       Date:  2010-07-18       Impact factor: 53.440

9.  Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses.

Authors:  Bao-Zhong Wang; Fu-Shi Quan; Sang-Moo Kang; Jadranka Bozja; Ioanna Skountzou; Richard W Compans
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

10.  Characterization of visna virus envelope neuraminic acid.

Authors:  M J August; D H Harter; R W Compans
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.